Showing results (1801-1810 of 2,369) with videos related to

Sort By:
Pageof 237
World Journal of Urology|April 28, 2024
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral centerFranceso Pellegrino, Riccardo Leni, Giuseppe Basile, et al.
World Journal of Urology|June 13, 2026
Serenoa Repens-Lycopene-Selenium and Epilobium-Palmitoylethanolamide-Calendula after transperineal prostate biopsy: a tertiary single center experiencePaolo Zaurito, Pietro Scilipoti, Armando Stabile, et al.
Annals of Surgical Oncology|October 19, 2010
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based studyLars Budäus, Maxine Sun, Firas Abdollah, et al.
European Urology|July 31, 2016
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care InstitutionsNicolò Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al.
International Journal of Cancer|April 25, 2007
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European menAndrea Gallina, Pierre I Karakiewicz, Georg C Hutterer, et al.
JACC. Cardiovascular Interventions|February 3, 2020
Carotid Wallstent Versus Roadsaver Stent and Distal Versus Proximal Protection on Cerebral Microembolization During Carotid Artery StentingPiero Montorsi, Luigi Caputi, Stefano Galli, et al.
The Journal of Urology|July 30, 2024
Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort AnalysisGiuseppe Ottone Cirulli, Matthew Davis, Alex Stephens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 TrialGiuseppe Basile, Marco Bandini, Ewan A Gibb, et al.
Urologic Oncology|October 23, 2021
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinomaRocco Simone Flammia, Francesco Chierigo, Christoph Würnschimmel, et al.
European Urology Focus|July 30, 2017
PD-L1 Expression and CD8+ T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate CancerFlorent Petitprez, Nicola Fossati, Yann Vano, et al.
Pageof 237